This suggests that access to and use of insulin delivery pumps are not to be relied upon in order to improve glycaemic control in a population of patients with T1DM; however, it should be noted that due to the limited sample size included in the study, this study did not reach the required power to be definitive [28]. This evidence concerns the gene INS and type 1 diabetes mellitus.